By Faye Duncan
Amsurg Corp (NASDAQ:AMSG) CEO
Christopher A. Holden sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $77.00, for a total transaction of $231,000.00. Following the completion of the transaction, the chief executive officer now owns 282,496 shares in the company, valued at approximately $21,752,192. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Several research firms recently issued reports on AMSG. Jefferies Group restated a “buy” rating on shares of Amsurg Corp in a research note on Tuesday, June 9th. Zacks upgraded shares of Amsurg Corp from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a research report on Monday, May 11th. Piper Jaffray restated a “buy” rating and issued a $82.00 price objective (up previously from $72.00) on shares of Amsurg Corp in a research report on Wednesday, August 5th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $75.00 target price (up previously from $67.00) on shares of Amsurg Corp in a research note on Thursday, May 7th. Finally, Goldman Sachs began coverage on shares of Amsurg Corp in a research note on Friday, June 5th. They set a “buy” rating and a $81.00 price objective on the stock. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $81.44.
